Investing Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II Finance News Sep 25, 2024 Overview Cardiol Therapeutics (NASDAQ:CRDL,TSX:CRDL) is a clinical-stage life sciences company focused on the… Read More...
Investing FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer Finance News Sep 20, 2024 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States… Read More...
Investing BCAL Commences US Operations Finance News Aug 27, 2024 BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) is pleased to announce that it has established a North… Read More...